期刊文献+

NFBD1在鼻咽癌组织中的表达及临床意义 被引量:3

Expressions of NFBD1 in nasopharyngeal carcinoma and their clinical significances
在线阅读 下载PDF
导出
摘要 目的:研究NFBD1在鼻咽癌(nasopharyngeal carcinoma,NPC)组织中的表达及其临床意义。方法:采用免疫组化检测40例NPC组织及20例慢性鼻咽炎组织中NFBD1蛋白的表达,实时荧光定量PCR检测34例NPC组织和23例慢性鼻咽炎组织中NFBD1 mRNA的表达并分析其与患者性别、年龄、颈淋巴结转移和临床分期的相关性。结果:NPC组织中NFBD1在蛋白水平(χ2=9.600,P=0.002)和mRNA水平(t=3.206,P=0.002)表达均高于慢性鼻咽炎组织,NFBD1在mRNA水平的表达高低与患者的性别(t=0.937,P=0.356)、年龄(t=0.382,P=0.698)及是否伴有临床颈淋巴结转移(t=1.037,P=0.322)、临床分期(t=0.293,P=0.771)均没有相关性。结论:NFBD1可能参与了NPC的发生,但其与NPC的侵袭转移没有明显联系。 Objective:To investigate the expressions of nuclear factor with BRCT domain 1 (NFBD 1) in nasopharyngeal carcinoma and their clinical significances. Methods:Expressions of NFBD1 protein in 40 cases of nasopharyngeal carcinoma(NPC)tissues and 20 cases of chronic nasopharyngitis tissues were detected by immunohistochemical SP method. Expressions of NFBD1 mRNA in 34 cases of NPC tissues and 23 cases of chronic nasopharyngitis tissues were observed by qRT-PCR and their correlations with patients'gender,age,cervical lymphnode metastasis and clinic stage were analyzed. Results:Expressions of NFBD1 protein and mRNA were sig- nificantly higher in NPC tissues than in chronic nasopharyngitis tissues(X2=9.6OO,P=O.OO2;t=3.206,P=-O.O02). Expressions of NFBD1 mRNA in NPC tissues were not significantly correlated with patient'gender(t=0.937,P=-0.356), age(t=0.382,P=0.698), cervical lymphnode metastasis (t= 1.037, P=0.322) and clinic stage (t =0.293, P=0.771). Conclusions : Overexpression of NFBD 1 may be involved in the tumorigenesis of NPC, but it is not significantly correlated with nasopharyngeal carcinoma invasion and metastasis.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2013年第2期126-130,共5页 Journal of Chongqing Medical University
基金 重庆市自然科学基金重点资助项目(编号:2012jjB10015) 重庆市卫生局资助项目(编号:2010220)
关键词 NFBD1 鼻咽癌 免疫组织化学 实时荧光定量PCR nuclear factor with BRCT domain 1 nasopharyngeal carcinoma immunohistochemistry real-time fluorescent quantitativePCR
作者简介 邱志利,研究方向:头颈肿瘤的基础与临床。Email:arlyqiu201@sina.com 胡国华,Email:hghcq@sina.com。
  • 相关文献

参考文献15

  • 1Zhou X F,Cui J,Macias V,et al.The progress on genetic analysis of nasopharyngeal carcinoma[J].Comp Funct Genomics, 2007,2007 : 57513.
  • 2Fandi A,Altun M,Azli N,et al.Nasopharyngeal cancer:epidemiology,staging,and treatment[J].Seminars in Oncology, 1994,21 (3) :382- 397.
  • 3Stucki M,Jackson S P.MDC1/NFBD1:a key regulator of the DNA damage response in higher eukaryotes[J].DNA Repair (Amst), 2004,3 (8-9) : 953-957.
  • 4Nagase T,Seki N,Ishikawa K A,et al.Prediction of the coding sequences of unidentified human genes V:the coding sequences of 40 new gene(KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell lines KGI[J].DNA Res, 1996,3(10):17-24.
  • 5Ozaki T,Nagase T,Ichimiya S,et al.NFBD1/KIAA0170 is a novel nuclear transcriptional transactivator with BRCT domain[J].DNA Cell Biol,2000,19(8) :475-485.
  • 6Yuan C,Bu Y,Wang C,et al.NFBD1/MDC1 is a protein of oncogenic potential in human cervical cancer[J].Mol Cell Biochemi,2012,359 (1-2) : 333-346.
  • 7刘丹丹,胡国华,刘学良,卜友泉.抑制NFBD1的表达对鼻咽癌化疗敏感性的影响[J].重庆医科大学学报,2012,37(5):393-396. 被引量:3
  • 8张新,吕晓丹,漆明,韩恩善,师志云.Egr-1与TNF-α在口腔扁平苔藓病损中表达的研究[J].重庆医科大学学报,2012,37(1):63-66. 被引量:6
  • 9Lou Z,Minter-Dykhouse K,Franco S,et al.MDC1 maintains genomic stability by participating in the amplification of the amplification of ATM-dependent DNA damage signals[J].Mol Ce11,2006,21 (2):187- 200.
  • 10Kastan M B,Bartek J.Cell-cycle checkpoint and cancer[J].Nature, 2004,432(7015) : 316-323.

二级参考文献14

共引文献7

同被引文献34

  • 1LEE F K,YIP C W,CHEUNG F C,et al.Dosimetric difference amongst 3 techniques:Tomo Therapy,sliding-window intensity-modulated radiotherapy(IMRT),and Rapid Arc radiotherapy in the treatment of late-stage nasopharyngeal carcinoma(NPC)[J].Med Dosim,2014,39(1):44-49.
  • 2BASSING C H,ALT F W.The cellular response to general and programmed DNA double strand breaks[J].DNA Repair(Amst),2004,3(8-9):781-796.
  • 3LIN S Y,LIANG Y,LI K.Multiple roles of BRIT1/MCPH1in DNA damage response,DNA repair,and cancer suppression[J].Yonsei Med J,2010,51(3):295-301.
  • 4MAI L,YI F,ZHANG J,et al.The overexpression of MCPH1inhibits cell growth through regulating cell cycle-related proteins and activating cytochrome c-caspase 3 signaling in cervical cancer[J].Mol Cell Biochem,2014,392(1-2):95-107.
  • 5BARAKAT K,GAJEWSKI M,TUSZYNSKI J A.DNA repair inhibitors:The next major step to improve cancer therapy[J].Curr Top Med Chem,2012,12(12):1376-1390.
  • 6RAI R,DAI H,MULTANI A S,et al.BRIT1 regulates early DNA damage response,chromosomal integrity,and cancer[J].Cancer Cell,2006,10(2):145-157.
  • 7XU X,LEE J,STERN D F.Microcephalin is a DNA damage response protein involved in regulation of CHK1 and BRCA1[J].J Biol Chem,2004,279(33):34091-34094.
  • 8LIN S Y,RAI R,LI K,et al.BRIT1/MCPH1 is a DNA damage responsive protein that regulates the Brcal--Chkl pathway,implicating checkpoint dysfunction in microcephaly[J].Proc Natl Acad Sci USA,2005,102(42):15105-15109.
  • 9BROWER V.Approval of provenge seen as first step for cancer treatment vaccines[J].J Natl Cancer Inst,2010,102(15):1108-1110.
  • 10KRUEGER A,BAUMANN S,KRAMMER P H,et al.FLICEinhibitory proteins:regulators of death receptor-mediated apoptosis[J].Mol Cell Biol,2001,21(24):8247-8254.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部